Loading…
Mangoceuticals, Inc. is projected to rise to $0.5285 by 2027, a +45% move from its current price of $0.365. MGRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.3421 | $0.3655 | $0.3905 | +0.14% |
| Jul 15 | $0.3333 | $0.366 | $0.4019 | +0.28% |
| Jul 16 | $0.3268 | $0.3665 | $0.411 | +0.42% |
| Jul 17 | $0.3215 | $0.367 | $0.4189 | +0.55% |
| Jul 18 | $0.317 | $0.3675 | $0.4261 | +0.69% |
| Jul 19 | $0.313 | $0.368 | $0.4328 | +0.83% |
| Jul 20 | $0.3094 | $0.3685 | $0.439 | +0.97% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3094 | $0.3685 | $0.439 | +0.97% |
| Week 2 | $0.2906 | $0.3721 | $0.4766 | +1.95% |
| Week 3 | $0.2775 | $0.3757 | $0.5088 | +2.94% |
| Week 4 | $0.2674 | $0.3794 | $0.5384 | +3.94% |
| Week 5 | $0.259 | $0.3831 | $0.5665 | +4.95% |
| Week 6 | $0.252 | $0.3868 | $0.5938 | +5.97% |
| Week 7 | $0.2458 | $0.3906 | $0.6205 | +7.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mangoceuticals, Inc. operates in the healthcare sector, developing, marketing, and selling men’s wellness products and services through a telemedicine platform in the United States.
The company markets erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.
Mangoceuticals, Inc. (MGRX) is currently priced at $0.3728 with a market cap of $6.4M and is ranked 5261.
The thirty-day price range runs from $0.2328 to $0.5969, and near-term technical context includes a neutral RSI of 50 with the SMA50 at $0.3842 and the SMA200 at $0.8954. Support is noted at $0.291 and resistance at $0.548.
A major floor 55.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.3% below — buyers have tended to step in here.
The nearest ceiling, 32.3% above — a clean break opens room to run.
A major ceiling 56.6% above — clearing it would confirm fresh momentum.
Key MGRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MGRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.382 | Sell | $0.3783 | Sell |
| MA 10 | $0.3927 | Sell | $0.3817 | Sell |
| MA 20 | $0.3682 | Sell | $0.3801 | Sell |
| MA 50 | $0.3827 | Sell | $0.3898 | Sell |
| MA 100 | $0.3915 | Sell | $0.4851 | Sell |
| MA 200 | $0.8657 | Sell | $0.8643 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.53 | Neutral |
| Stoch RSI (14) | 40.70 | Neutral |
| CCI (20) | -8.07 | Neutral |
| Williams %R (14) | -58.66 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 5.19 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 41.34 | Neutral |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 49.19 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.36 | Buy |
| ADX (14) | 9.99 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL with RSI(14) at 50.
The price sits near the SMA50 of $0.3842 and below the SMA200 of $0.8954, with near-term support at $0.291 and resistance at $0.548.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.162 | $0.365 | $0.6369 | 0% | Neutral | |
| $0.3834 | $0.5285 | $0.7875 | +45% | Bullish | |
| $0.468 | $0.6855 | $1.09 | +88% | Bullish | |
| $0.4176 | $0.6443 | $1.07 | +77% | Bullish | |
| $0.3424 | $0.5539 | $0.9613 | +52% | Bullish | |
| $0.3463 | $0.5855 | $1.05 | +60% | Bullish | |
| $0.2894 | $0.5102 | $0.9451 | +40% | Bullish | |
| $0.3824 | $0.7023 | $1.34 | +92% | Bullish | |
| $0.4909 | $0.9377 | $1.83 | +157% | Bullish | |
| $0.4144 | $0.8229 | $1.64 | +125% | Bullish | |
| $0.4986 | $1.11 | $2.43 | +204% | Bullish | |
| $0.7971 | $1.77 | $4.07 | +385% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.162 | $0.365 | $0.4868 | +0.00% |
| August 2026 | $0.3449 | $0.4177 | $0.5268 | +14.43% |
| September 2026 | $0.337 | $0.414 | $0.5332 | -0.88% |
| October 2026 | $0.363 | $0.4514 | $0.5915 | +9.03% |
| November 2026 | $0.3893 | $0.4892 | $0.6504 | +8.39% |
| December 2026 | $0.3726 | $0.4728 | $0.6369 | -3.36% |
Click any year to see its month-by-month MGRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MGRX to range from $0.162 to $0.6369 through 2026. The $0.365 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MGRX price prediction for 2027 points to an average of $0.5285 (low $0.3834, high $0.7875) — a potential gain of +45% on today's $0.365. Momentum favours further upside here.
In 2028, MGRX is projected to trade between $0.468 and $1.09, averaging $0.6855 — a potential gain of +88% from today's $0.365. That is up +30% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Mangoceuticals, Inc.'s 2029 outlook centres on $0.6443, within a $0.4176 to $1.07 range. That is -6% versus the projected 2028 average. That marks a +77% change versus current levels. Momentum favours further upside here.
By 2030, MGRX could reach as high as $0.9613, with a base case around $0.5539 and support toward $0.3424 — roughly +52% from $0.365. Buyers look set to stay in control over this stretch.
Expect MGRX to range from $0.3463 to $1.05 through 2031. The $0.5855 average target implies a +60% move from current prices. That is up +6% on the projected 2030 average. Momentum favours further upside here.
The MGRX price prediction for 2032 points to an average of $0.5102 (low $0.2894, high $0.9451) — a potential gain of +40% on today's $0.365. Buyers look set to stay in control over this stretch.
In 2033, MGRX is projected to trade between $0.3824 and $1.34, averaging $0.7023 — a potential gain of +92% from today's $0.365. That is up +38% on the projected 2032 average. Momentum favours further upside here.
Mangoceuticals, Inc.'s 2034 outlook centres on $0.9377, within a $0.4909 to $1.83 range. That is up +34% on the projected 2033 average. That marks a +157% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MGRX could reach as high as $1.64, with a base case around $0.8229 and support toward $0.4144 — roughly +125% from $0.365. Momentum favours further upside here.
Expect MGRX to range from $0.4986 to $2.43 through 2040. The $1.11 average target implies a +204% move from current prices. That is up +35% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MGRX price prediction for 2050 points to an average of $1.77 (low $0.7971, high $4.07) — a potential gain of +385% on today's $0.365. Momentum favours further upside here.
Investing $1,000 in MGRX today (≈ 2,739.726027 MGRX) could be worth
$4,852.76
+$3,852.76 (+385%) by 2050 · US Dollar
Based on the average projected MGRX price of $1.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MGRXwould be worth at today's price.
$1,000 invested in MGRX on Jul 10, 2025 (≈ 606.060615 MGRX) would be worth
$221.21
-$778.79 (-77.9%) today · 0.22× · US Dollar
Based on a MGRX entry price of $1.65 vs. today's $0.365.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.47 | $776.6 | -22.3% |
| 1 month ago | $0.36 | $1,013.89 | +1.4% |
| 3 months ago | $0.34 | $1,073.53 | +7.4% |
| 6 months ago | $0.785 | $464.97 | -53.5% |
| 1 year ago | $1.65 | $221.21 | -77.9% |
| All time (3.3y) ago | $60 | $6.08 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MGRX forecast.
Our base-case forecast reaches $0.73 around 2034.
Implied market cap at $0.73: $12.53M
Forecasts for 2026 show a min of $0.162, an avg of $0.3728, and a max of $0.6512, with ROI of 0% and sentiment NEUTRAL.
From 2027 onward, the outlook turns bullish, with 2027 avg $0.5496 and max $0.8197 (ROI 47.4%), 2028 avg $0.705 (ROI 89.1%), 2029 avg $0.6582 (ROI 76.6%), 2030 avg $0.5713 (ROI 53.3%), 2031 avg $0.6057 (ROI 62.5%), and 2032 avg $0.5319 (ROI 42.7%). The sequence continues with 2033 avg $0.7497 (ROI 101.1%), 2034 avg $0.988 (ROI 165%), and 2035 avg $0.8526 (ROI 128.7%), followed by 2040 avg $1.19 (ROI 219.6%), and 2050 avg $1.86 (ROI 398.1%). Bulls are noted in the forecast across these years.
Tap a question to reveal the answer.
2027 forecast: min $0.3985, avg $0.5496, max $0.8197; ROI 47.4%; sentiment BULLISH.
The forecast shows a path higher on average from 2026 ($0.3728) toward 2050 ($1.86 avg; $4.27 max), with ROIs up to 398.1% and bullish sentiment in later years. These are estimates, not guarantees, and not financial advice.
Yes—the max forecast by 2040 is $2.62 and by 2050 is $4.27, indicating potential over $2 at later dates.
Current price is $0.3728 and market cap is $6.4M.
RSI(14) is 50; SMA50 is $0.3842; SMA200 is $0.8954. The stock shows a 30-day range of $0.2328 to $0.5969 with support at $0.291 and resistance at $0.548; annualized volatility is 100%.
Mangoceuticals, Inc. Community Discussion
0Share your Mangoceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.